<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>NanoCRISPR therapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/nanocrispr-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 22 Oct 2025 16:45:39 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>NanoCRISPR therapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>NanoCRISPR Tool Reduces Metastasis by Targeting HO-1 Gene</title>
		<link>https://bioengineer.org/nanocrispr-tool-reduces-metastasis-by-targeting-ho-1-gene/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 22 Oct 2025 16:45:17 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Cancer immunotherapy]]></category>
		<category><![CDATA[HO-1 gene targeting]]></category>
		<category><![CDATA[metastasis reduction]]></category>
		<category><![CDATA[NanoCRISPR therapy]]></category>
		<category><![CDATA[tumor resistance breakthrough]]></category>
		<guid isPermaLink="false">https://bioengineer.org/nanocrispr-tool-reduces-metastasis-by-targeting-ho-1-gene/</guid>

					<description><![CDATA[Recent advancements in cancer immunotherapy have opened new avenues for harnessing the body’s immune response against tumors. Among these innovative strategies, photodynamic therapy (PDT) has gained prominence for its ability to induce immunogenic cell death, effectively transforming dying cancer cells into self-sufficient vaccines. However, the underlying challenge remains: many tumors possess innate genetic tolerance mechanisms [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">285264</post-id>	</item>
	</channel>
</rss>
